Anthony Hayes, CEO at AIkido Pharma Inc. (AIKI), bought 5,000 shares at $3.48 ($17K) on 2022-12-07, disclosed to the SEC on 2022-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DOMH | BUY | 2024-05-31 | $11K | — | Filing → |
| DOMH | BUY | 2024-04-08 | $49K | — | Filing → |
| DOMH | BUY | 2023-12-22 | $140K | — | Filing → |